By Sara E. Rainey, PharmD, RPh, 340 ACE
Visante’s attendance at the 2025 340B Winter Coalition Conference proved both insightful and impactful. Discussions, policy updates and industry trends provided valuable insights into the future of the 340B program. While there was much to unpack, here are three key takeaways that our team found most critical.
1. Leadership Changes at the Federal Level
A new Trump administration brings leadership changes to Washington, D.C. Key roles relevant to 340B